In an effort to expedite the on-boarding process stipulated in Directive 2011/62/EU, the European Medicines Verification Organisation (EMVO) is circulating a letter of announcement to manufacturers, marketing authorisation holders and parallel traders with information material on how companies are to engage in the on-boarding portal. Further details can be accessed on the following EMVO platform: https://emvo-medicines.eu/